The Oncosearch | Oncotarget

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma Research Paper

Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Soyeon Kim, Yong-Oon Ahn, Eun-Jae Chung, Jin-Ho Kim, Tae Min Kim, Seong Keun Kwon, Yoon Kyung Jeon, Kyeong Chun Jung, Dong-Wan Kim, Hong-Gyun Wu, Myung-Whun Sung, Dae Seog Heo

Published Jun 16, 2017 · Vol. 8, No. 58 · pp. 97920-97927

The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas Review

Gonzalo Carrasco-Avino, Ismael Riquelme, Oslando Padilla, Miguel Villaseca, Francisco R. Aguayo, Alejandro H. Corvalan

Published Jun 15, 2017 · Vol. 8, No. 43 · pp. 75687-75698

Tumor reductive therapies and antitumor immunity Review

Huiqin Guo, Kangla Tsung

Published Jun 14, 2017 · Vol. 8, No. 33 · pp. 55736-55749

The efficacy of anti-PD-1/PD-L1 therapy and its comparison with EGFR-TKIs for advanced non-small-cell lung cancer Review

Zhixin Sheng, Xu Zhu, Yanhua Sun, Yanxia Zhang

Published Jun 8, 2017 · Vol. 8, No. 34 · pp. 57826-57835

Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition Priority Research Paper

Sebastian Peer, Gottfried Baier, Thomas Gruber

Published Jun 3, 2017 · Vol. 8, No. 26 · pp. 41841-41853

Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature review Case Report

Young Kwang Chae, Si Wang, Halla Nimeiri, Aparna Kalyan, Francis J. Giles

Published Jun 3, 2017 · Vol. 8, No. 34 · pp. 57889-57897

Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer Review

Xinxin Zhu, Jinghe Lang

Published May 31, 2017 · Vol. 8, No. 57 · pp. 97671-97682

Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis Review

Xiaohui Wang, Zhengqiang Bao, Xiaoju Zhang, Fei Li, Tianwen Lai, Chao Cao, Zhihua Chen, Wen Li, Huahao Shen, Songmin Ying

Published May 31, 2017 · Vol. 8, No. 35 · pp. 59901-59914

PD-L1 and intratumoral immune response in breast cancer Research Paper

Zhi-Qiang Wang, Katy Milne, Heather Derocher, John R. Webb, Brad H. Nelson, Peter H. Watson

Published May 30, 2017 · Vol. 8, No. 31 · pp. 51641-51651

Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: Implications for immunotherapy Research Paper

Kellie B. Haworth, Michael A. Arnold, Christopher R. Pierson, Kwangmin Choi, Nicholas D. Yeager, Nancy Ratner, Ryan D. Roberts, Jonathan L. Finlay, Timothy P. Cripe

Published May 30, 2017 · Vol. 8, No. 47 · pp. 82037-82048

Prognostic significance of PD-L1 expression and ¹⁸F-FDG PET/CT in surgical pulmonary squamous cell carcinoma Research Paper

Minghui Zhang, Dalong Wang, Qi Sun, Haihong Pu, Yan Wang, Shu Zhao, Yan Wang, Qiangyuan Zhang

Published May 29, 2017 · Vol. 8, No. 31 · pp. 51630-51640

Expression of LAG-3 defines exhaustion of intratumoral PD-1⁺ T cells and correlates with poor outcome in follicular lymphoma Research Paper

Zhi-Zhang Yang, Hyo Jin Kim, Jose C. Villasboas, Ya-Ping Chen, Tammy Price-Troska, Shahrzad Jalali, Mara Wilson, Anne J. Novak, Stephen M. Ansell

Published May 29, 2017 · Vol. 8, No. 37 · pp. 61425-61439

Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells Research Paper

Jonas R.M. Van Audenaerde, Jorrit De Waele, Elly Marcq, Jinthe Van Loenhout, Eva Lion, Johan M.J. Van den Bergh, Ralf Jesenofsky, Atsushi Masamune, Geert Roeyen, Patrick Pauwels, Filip Lardon, Marc Peeters, Evelien L.J. Smits

Published May 25, 2017 · Vol. 8, No. 34 · pp. 56968-56979

The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs Research Paper

Hee Kyung Kim, Sang Yun Ha, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Young Suk Park, Seung Tae Kim

Published May 25, 2017 · Vol. 8, No. 43 · pp. 73974-73980

Activation of the ATF2/CREB-PGC-1Î± pathway by metformin leads to dopaminergic neuroprotection Research Paper

Hojin Kang, Rin Khang, Sangwoo Ham, Ga Ram Jeong, Hyojung Kim, Minkyung Jo, Byoung Dae Lee, Yun Il Lee, Areum Jo, ChiHu Park, Hyein Kim, Jeongkon Seo, Sun Ha Paek, Yun-Song Lee, Jeong-Yun Choi, Yunjong Lee, Joo-Ho Shin

Published May 24, 2017 · Vol. 8, No. 30 · pp. 48603-48618

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer Research Paper

Anderly C. ChÃ¼eh, Mun-Sem Liew, Prudence A. Russell, Marzena Walkiewicz, Aparna Jayachandran, Maud H.W. Starmans, Paul C. Boutros, Gavin Wright, Stephen A. Barnett, John M. Mariadason, Thomas John

Published May 23, 2017 · Vol. 8, No. 43 · pp. 74036-74048

Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy Research Paper

Xiaxing Deng, Xi Cheng, Zhen Huo, Yuan Shi, Zhijian Jin, Haoran Feng, Yue Wang, Chenlei Wen, Hao Qian, Ren Zhao, Weihua Qiu, Baiyong Shen, Chenghong Peng

Published May 23, 2017 · Vol. 8, No. 29 · pp. 47841-47848

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma Research Paper

Jinfeng Cao, Niels J. Brouwer, Kate E. Richards, Marina Marinkovic, Sjoerd van Duinen, Daan Hurkmans, Els M.E. Verdegaal, Ekaterina S. Jordanova, Martine J. Jager

Published May 20, 2017 · Vol. 8, No. 33 · pp. 54722-54734

Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma Research Paper

Song Xue, Man Hu, Peifeng Li, Ji Ma, Li Xie, Feifei Teng, Yufang Zhu, Bingjie Fan, Dianbin Mu, Jinming Yu

Published May 17, 2017 · Vol. 8, No. 30 · pp. 49702-49712

HDAC inhibitors enhance the immunotherapy response of melanoma cells Research Paper

Laurence Booth, Jane L. Roberts, Andrew Poklepovic, John Kirkwood, Paul Dent

Published May 17, 2017 · Vol. 8, No. 47 · pp. 83155-83170

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma Research Paper

The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas Review

Tumor reductive therapies and antitumor immunity Review

The efficacy of anti-PD-1/PD-L1 therapy and its comparison with EGFR-TKIs for advanced non-small-cell lung cancer Review

Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition Priority Research Paper

Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature review Case Report

Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer Review

Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis Review

PD-L1 and intratumoral immune response in breast cancer Research Paper

Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: Implications for immunotherapy Research Paper

Prognostic significance of PD-L1 expression and ¹⁸F-FDG PET/CT in surgical pulmonary squamous cell carcinoma Research Paper

Expression of LAG-3 defines exhaustion of intratumoral PD-1⁺ T cells and correlates with poor outcome in follicular lymphoma Research Paper

Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells Research Paper

The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs Research Paper

Activation of the ATF2/CREB-PGC-1Î± pathway by metformin leads to dopaminergic neuroprotection Research Paper

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer Research Paper

Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy Research Paper

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma Research Paper

Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma Research Paper

HDAC inhibitors enhance the immunotherapy response of melanoma cells Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma Research Paper

The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas Review

Tumor reductive therapies and antitumor immunity Review

The efficacy of anti-PD-1/PD-L1 therapy and its comparison with EGFR-TKIs for advanced non-small-cell lung cancer Review

Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibition Priority Research Paper

Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature review Case Report

Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer Review

Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis Review

PD-L1 and intratumoral immune response in breast cancer Research Paper

Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: Implications for immunotherapy Research Paper

Prognostic significance of PD-L1 expression and 18F-FDG PET/CT in surgical pulmonary squamous cell carcinoma Research Paper

Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma Research Paper

Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells Research Paper

The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs Research Paper

Activation of the ATF2/CREB-PGC-1Î± pathway by metformin leads to dopaminergic neuroprotection Research Paper

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer Research Paper

Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy Research Paper

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma Research Paper

Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma Research Paper

HDAC inhibitors enhance the immunotherapy response of melanoma cells Research Paper

Prognostic significance of PD-L1 expression and ¹⁸F-FDG PET/CT in surgical pulmonary squamous cell carcinoma Research Paper

Expression of LAG-3 defines exhaustion of intratumoral PD-1⁺ T cells and correlates with poor outcome in follicular lymphoma Research Paper